In a move that reflects the increasingly competitive nature of the weight-loss treatment space, AstraZeneca bought the rights to a GLP-1 drug candidate from Eccogene for $185 million upfront Thursday morning
A physician-guided plan may help reduce side effects through slower dose escalation, hydration guidance, meal-size changes, constipation prevention, protein planning, and medication review
Across these trials, tirzepatide delivered dose-dependent improvements in glycemic control and body weight, often surpassing comparators like semaglutide and dulaglutide (43)(44)
This includes medication, provider review, supplies, and shipping with no additional fees
Send us an e-mail to [email protected] with your exact order request, phone number and address and we will be happy to send you a parcel